Takanashi Ken
- SEC CIK
- 0001657768
In the past year, 1 open-market sale filing worth $23.2K and no purchases.
Current role at each company
- WVE Wave Life Sciences, Inc.Directoras of Aug 13, 2026
- STSA Satsuma Pharmaceuticals, Inc.Director, 10% Owneras of Jun 8, 2023
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- $23.2K
- 1 filing
- Net
- −$23.2K
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists Takanashi Ken as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
WVE Wave Life Sciences, Inc.
Director2 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Aug 13, 2026 (view filing)9:00 PM ET | Aug 11 | 2 days | Takanashi KenDirector | SSale | −3.86K | $6.01 | −$23.2K | −16.1%20.1K after | 10b5-1 |
| Aug 7, 2025 (view filing) | Aug 5 | 2 days | Takanashi KenDirector | SSale | −4.87K | $8.75 | −$42.6K | −0.1%5.72M after | 10b5-1 |
STSA Satsuma Pharmaceuticals, Inc.
Director, 10% Owner1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jun 8, 2023 (view filing) | Jun 6 | 2 days | Takanashi KenDirector, 10% Owner | PPurchaseCommon Stock, $0.0001 par value | +22.1M | $0.91 | +$20.1M | +789.3%24.8M after |